I think RVX should wait for the FDA to get on board. That being said, they could run a trial outside the U.S. If it was approved by other regulatory bodies. However, the FDA would not necessarily want to use data from that trial to decide on the approval of 208. Get the funding in place, get all the approvals in place and get the right trial started. Do it once and do it properly :) Bfw